Upcoming Dividend • Aug 14
Upcoming dividend of ₹0.30 per share Eligible shareholders must have bought the stock before 21 August 2026. Payment date: 27 September 2026. Payout ratio is a comfortable 1.4% but the company is not cash flow positive. The company last paid an ordinary dividend in March 2016. The average dividend yield among industry peers is 0.7%. Reported Earnings • Aug 03
First quarter 2027 earnings released: EPS: ₹5.89 (vs ₹4.79 in 1Q 2026) First quarter 2027 results: EPS: ₹5.89 (up from ₹4.79 in 1Q 2026). Revenue: ₹4.33b (up 25% from 1Q 2026). Net income: ₹396.4m (up 23% from 1Q 2026). Profit margin: 9.1% (down from 9.3% in 1Q 2026). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.7% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth. Declared Dividend • Jul 24
Dividend of ₹0.30 announced Dividend of ₹0.30 is the same as last year. Ex-date: 21st August 2026 Payment date: 27th September 2026 Dividend yield will be 0.05%, which is lower than the industry average of 0.8%. Annonce • Jul 23
Vishnu Chemicals Limited to Report Q1, 2027 Results on Aug 01, 2026 Vishnu Chemicals Limited announced that they will report Q1, 2027 results at 12:15 PM, Indian Standard Time on Aug 01, 2026 Annonce • Jul 22
Vishnu Chemicals Limited, Annual General Meeting, Aug 28, 2026 Vishnu Chemicals Limited, Annual General Meeting, Aug 28, 2026, at 11:00 Indian Standard Time. Reported Earnings • Jun 01
Full year 2026 earnings: EPS and revenues exceed analyst expectations Full year 2026 results: EPS: ₹21.14 (up from ₹19.23 in FY 2025). Revenue: ₹16.3b (up 13% from FY 2025). Net income: ₹1.42b (up 12% from FY 2025). Profit margin: 8.7% (down from 8.8% in FY 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.5%. Earnings per share (EPS) also surpassed analyst estimates by 7.3%. Revenue is forecast to grow 9.4% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Annonce • May 30
Vishnu Chemicals Limited Recommends Dividend for the Financial Year Ended March 31, 2026 Vishnu Chemicals Limited announced that at the board meeting held on May 22, 2026, recommended dividend of INR 0.30 per equity share of INR 2 each (i.e. 15%) for the financial year ended March 31, 2026 and the same shall be paid subject To Approve the shareholders at ensuing Annual General Meeting. Annonce • May 22
Vishnu Chemicals Limited to Report Q4, 2026 Results on May 30, 2026 Vishnu Chemicals Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026 Reported Earnings • Feb 01
Third quarter 2026 earnings released: EPS: ₹5.02 (vs ₹5.25 in 3Q 2025) Third quarter 2026 results: EPS: ₹5.02 (down from ₹5.25 in 3Q 2025). Revenue: ₹4.18b (up 13% from 3Q 2025). Net income: ₹337.6m (down 1.8% from 3Q 2025). Profit margin: 8.1% (down from 9.3% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Annonce • Jan 23
Vishnu Chemicals Limited to Report Q3, 2026 Results on Jan 31, 2026 Vishnu Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 31, 2026 Board Change • Jan 01
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Naga Bhagwati was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 07
Second quarter 2026 earnings released: EPS: ₹4.88 (vs ₹3.49 in 2Q 2025) Second quarter 2026 results: EPS: ₹4.88 (up from ₹3.49 in 2Q 2025). Revenue: ₹4.11b (up 19% from 2Q 2025). Net income: ₹328.8m (up 44% from 2Q 2025). Profit margin: 8.0% (up from 6.6% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings. Annonce • Oct 31
Vishnu Chemicals Limited to Report Q2, 2026 Results on Nov 06, 2025 Vishnu Chemicals Limited announced that they will report Q2, 2026 results on Nov 06, 2025 Annonce • Aug 14
Vishnu Chemicals Limited Approves Final Dividend for the Financial Year Ended March 31, 2025 Vishnu Chemicals Limited, at the AGM held on August 14, 2025 approved final dividend of INR 0.30 per equity share of INR 2/each (i.e. 15%) for the financial year ended March 31, 2025. Annonce • Aug 04
Vishnu Chemicals Limited Announces Cessation of Tirthankar Mitra as Independent Director of the Company, with Effect from August 13, 2025 Vishnu Chemicals Limited informed that at the meeting of Board of Directors held on August 02, 2025, the Board considered and took note of the completion of second term of Mr. Tirthankar Mitra (DIN: 02675454), Independent Director of the Company, with effect from August 13, 2025. The Board of Directors place on record their appreciation for the valuable contribution and guidance provided by Mr. Tirthankar Mitra during his tenure with the Company. Upcoming Dividend • Aug 01
Upcoming dividend of ₹0.30 per share Eligible shareholders must have bought the stock before 08 August 2025. Payment date: 13 September 2025. Payout ratio is a comfortable 1.6% and the cash payout ratio is 85%. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%). Annonce • Jul 28
Vishnu Chemicals Limited to Report Q1, 2026 Results on Aug 02, 2025 Vishnu Chemicals Limited announced that they will report Q1, 2026 results on Aug 02, 2025 Reported Earnings • Jul 25
Full year 2025 earnings: EPS exceeds analyst expectations Full year 2025 results: EPS: ₹19.23 (up from ₹15.90 in FY 2024). Revenue: ₹14.5b (up 19% from FY 2024). Net income: ₹1.27b (up 25% from FY 2024). Profit margin: 8.8% (up from 8.3% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 6.2%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Annonce • Jul 02
Vishnu Chemicals Limited, Annual General Meeting, Aug 14, 2025 Vishnu Chemicals Limited, Annual General Meeting, Aug 14, 2025, at 11:00 Indian Standard Time. Board Change • Jun 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. Independent Director Naga Bhagwati was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹376, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 16% over the past three years. Reported Earnings • Jan 25
Third quarter 2025 earnings released: EPS: ₹5.25 (vs ₹3.17 in 3Q 2024) Third quarter 2025 results: EPS: ₹5.25 (up from ₹3.17 in 3Q 2024). Revenue: ₹3.74b (up 23% from 3Q 2024). Net income: ₹344.0m (up 66% from 3Q 2024). Profit margin: 9.2% (up from 6.8% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Jan 24
Vishnu Chemicals Limited Announces Completion of Second Term of Chetan Navinchandra Shah as Independent Director, with Effect from February 11, 2025 Vishnu Chemicals Limited announced that at the meeting of Board of Directors held on January 24, 2025, the Board considered and took note of the completion of second term of Mr. Chetan Navinchandra Shah (DIN: 08038633), Independent Director of the Company, with effect from February 11, 2025. The Board of Directors place on record their appreciation for the valuable contribution and guidance provided by Mr. Chetan Navinchandra Shah during his tenure with the Company. Cessation due to completion of second term of appointment of Mr. Chetan Navinchandra Shah (DIN: 08038633) with effect from February 11, 2025. Annonce • Dec 02
Vishnu Chemicals Limited (BSE:516072) acquired Jayansree Pharma Private Limited from it's shareholders. Vishnu Chemicals Limited (BSE:516072) entered into a share purchase agreement to acquire Jayansree Pharma Private Limited from it's shareholders for an enterprise value of INR 520 million on August 19, 2024. The consideration will be paid in the form of cash. Following the acquisition Jayansree Pharma will manufacture Speciality chemicals and operate in allied area, in-line with the company. For the period ending March 31, 2023, Jayansree Pharma Private Limited reported a turonver of INR 295.4 million. The transaction has been approved by the board of Vishnu Chemicals. The transaction is expected to be completed within 3 months.
Vishnu Chemicals Limited (BSE:516072) completed the acquisition of Jayansree Pharma Private Limited from it's shareholders on November 30, 2024. Upcoming Dividend • Sep 13
Upcoming dividend of ₹0.30 per share Eligible shareholders must have bought the stock before 20 September 2024. Payment date: 27 October 2024. Payout ratio is a comfortable 1.9% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%). Annonce • Aug 30
Vishnu Chemicals Limited announced a financing transaction Vishnu Chemicals Limited announced a private placement to issue 7% 76,637,500,Compulsory Convertible Preference Shares on August 28, 2024. Hence, the CCPS will be issued and allotted to the existing CRPS holders and subsequently the said CCPS will be converted by issue and allotment of 1,788,089 Equity Shares of face value of INR 2 each at a price of INR 428.60 per Equity Share. The transaction will include participation from Krishna Murthy, Manjula and Siddartha. The transaction has been approved by shareholders of company. Annonce • Aug 20
Vishnu Chemicals Limited (BSE:516072) entered into a share purchase agreement to acquire Jayansree Pharma Private Limited from it's shareholders for an enterprise value of INR 520 million. Vishnu Chemicals Limited (BSE:516072) entered into a share purchase agreement to acquire Jayansree Pharma Private Limited from it's shareholders for an enterprise value of INR 520 million on August 19, 2024. The consideration will be paid in the form of cash. Following the acquisition Jayansree Pharma will manufacture Speciality chemicals and operate in allied area, in-line with the company. For the period ending March 31, 2023, Jayansree Pharma Private Limited reported a turonver of INR 295.4 million. The transaction has been approved by the board of Vishnu Chemicals. The transaction is expected to be completed within 3 months. Reported Earnings • Aug 15
First quarter 2025 earnings released: EPS: ₹4.65 (vs ₹4.79 in 1Q 2024) First quarter 2025 results: EPS: ₹4.65. Revenue: ₹3.42b (up 14% from 1Q 2024). Net income: ₹304.7m (up 6.4% from 1Q 2024). Profit margin: 8.9% (in line with 1Q 2024). Annonce • Aug 09
Vishnu Chemicals Limited to Report Q1, 2025 Results on Aug 14, 2024 Vishnu Chemicals Limited announced that they will report Q1, 2025 results on Aug 14, 2024 Annonce • Aug 02
Vishnu Chemicals Limited, Annual General Meeting, Sep 27, 2024 Vishnu Chemicals Limited, Annual General Meeting, Sep 27, 2024, at 11:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Jun 10
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹372, the stock trades at a trailing P/E ratio of 24.1x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 325% over the past three years. Annonce • May 27
Vishnu Chemicals Limited Recommends Dividend for the Financial Year Ended March 31, 2024 Vishnu Chemicals Limited announced that at its board meeting held on May 25, 2024, recommended dividend of INR 0.30/- per equity share of INR 2/- each (i.e. 15%) for the financial year ended 31st March, 2024 and the same shall be paid subject To Approve the shareholders at up coming Annual/General Meeting. Further, record date for the purpose of dividend and scheduled date of the 31st AGM will be informed in due course. Reported Earnings • May 27
Full year 2024 earnings released: EPS: ₹15.90 (vs ₹22.86 in FY 2023) Full year 2024 results: EPS: ₹15.90 (down from ₹22.86 in FY 2023). Revenue: ₹12.3b (down 12% from FY 2023). Net income: ₹1.01b (down 26% from FY 2023). Profit margin: 8.3% (down from 9.8% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth. Annonce • May 17
Vishnu Chemicals Limited to Report Q4, 2024 Results on May 25, 2024 Vishnu Chemicals Limited announced that they will report Q4, 2024 results at 3:30 PM, Indian Standard Time on May 25, 2024 Valuation Update With 7 Day Price Move • Mar 20
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹294, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 439% over the past three years. Annonce • Feb 03
Vishnu Chemicals Limited to Report Q3, 2024 Results on Feb 12, 2024 Vishnu Chemicals Limited announced that they will report Q3, 2024 results on Feb 12, 2024 Reported Earnings • Nov 11
Second quarter 2024 earnings released: EPS: ₹3.77 (vs ₹5.88 in 2Q 2023) Second quarter 2024 results: EPS: ₹3.77 (down from ₹5.88 in 2Q 2023). Revenue: ₹3.08b (down 17% from 2Q 2023). Net income: ₹239.9m (down 32% from 2Q 2023). Profit margin: 7.8% (down from 9.5% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has increased by 111% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Nov 06
Vishnu Chemicals Limited to Report Q2, 2024 Results on Nov 08, 2023 Vishnu Chemicals Limited announced that they will report Q2, 2024 results on Nov 08, 2023 Annonce • Aug 05
Vishnu Chemicals Limited to Report Q1, 2024 Results on Aug 14, 2023 Vishnu Chemicals Limited announced that they will report Q1, 2024 results on Aug 14, 2023 Annonce • Aug 01
Vishnu Chemicals Limited has completed a Follow-on Equity Offering in the amount of INR 1.999998 billion. Vishnu Chemicals Limited has completed a Follow-on Equity Offering in the amount of INR 1.999998 billion.
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 5,797,095
Price\Range: INR 345
Transaction Features: Regulation S; Subsequent Direct Listing Annonce • Jul 04
Vishnu Chemicals Limited, Annual General Meeting, Aug 11, 2023 Vishnu Chemicals Limited, Annual General Meeting, Aug 11, 2023, at 11:00 Indian Standard Time. Reported Earnings • May 05
Full year 2023 earnings released Full year 2023 results: Revenue: ₹14.1b (up 32% from FY 2022). Net income: ₹1.37b (up 68% from FY 2022). Profit margin: 9.7% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: ₹5.31 (vs ₹4.12 in 3Q 2022) Third quarter 2023 results: EPS: ₹5.31 (up from ₹4.12 in 3Q 2022). Revenue: ₹3.25b (up 9.2% from 3Q 2022). Net income: ₹317.4m (up 29% from 3Q 2022). Profit margin: 9.8% (up from 8.3% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has increased by 120% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Feb 11
Vishnu Chemicals Limited Appoints Mahesh Bhatter as Chief Financial Officer Vishnu Chemicals Limited at its board of directors meeting held on February 10, 2023 appointed Mahesh Bhatter as Chief Financial Officer and Key Managerial Personnel (KMP) of the Company based on the recommendations of the Nomination and Remuneration Committee and the Audit Committee, with effect from February 10, 2023. Mr. Mahesh Bhatter is an Associate Member of both The Institute of Chartered Accountants of India and The Institute of Company Secretaries of India. He is also a Certified Treasury Manager from ICFAI, Tripura and Certified Corporate Finance Professional from Dun & Bradstreet. He has completed Bachelor of Commerce (Hons) from University of Calcutta. He has been associated with Vishnu Chemicals Limited since September, 2018 and has over 17 years of Corporate experience in the diversified fields of Accounts, Corporate Finance, Forex, Treasury, Project Finance,Working Capital Management etc.He has successfully completed the Corporate Debt Restructuring with CDR Cell in the past and possesses expertise in cost reduction of Bank loans through various alternate financing arrangement. He has enriched experience in various manufacturing industries such as Iron & Steel, Ferro Alloy, Garments, Pharmaceuticals, Specialty Chemicals and Commodities like Coal & Coke. Annonce • Jan 25
Vishnu Chemicals Limited to Report Q3, 2023 Results on Feb 10, 2023 Vishnu Chemicals Limited announced that they will report Q3, 2023 results at 12:15 PM, Indian Standard Time on Feb 10, 2023 Annonce • Jan 23
Vishnu Chemicals Limited Announces Sudden and Sad Demise of P Anjaneyulu, Chief Financial Officer of the Company on 21 January, 2023 Vishnu Chemicals Limited announced the sudden and sad demise of Mr. P Anjaneyulu, Chief Financial Officer & Key Managerial Personnel of the Company on 21 January, 2023. Mr. P Anjaneyulu's unexpected passing away will be an irreparable loss to the Company and all the Directors and Employees of the Company convey deep sympathy, sorrow and condolences to his family. Reported Earnings • Nov 02
Second quarter 2023 earnings released: EPS: ₹29.40 (vs ₹13.92 in 2Q 2022) Second quarter 2023 results: EPS: ₹29.40 (up from ₹13.92 in 2Q 2022). Revenue: ₹3.75b (up 56% from 2Q 2022). Net income: ₹351.2m (up 111% from 2Q 2022). Profit margin: 9.4% (up from 6.9% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has increased by 136% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 07
First quarter 2023 earnings released: EPS: ₹28.52 (vs ₹9.70 in 1Q 2022) First quarter 2023 results: EPS: ₹28.52 (up from ₹9.70 in 1Q 2022). Revenue: ₹3.61b (up 83% from 1Q 2022). Net income: ₹340.6m (up 194% from 1Q 2022). Profit margin: 9.4% (up from 5.9% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has increased by 136% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Jun 30
Upcoming dividend of ₹2.00 per share Eligible shareholders must have bought the stock before 07 July 2022. Payment date: 13 August 2022. Payout ratio is a comfortable 2.9% but the company is paying out more than the cash it is generating. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.8%). Lower than average of industry peers (0.8%). Reported Earnings • Jun 24
Full year 2022 earnings released: EPS: ₹68.13 (vs ₹28.88 in FY 2021) Full year 2022 results: EPS: ₹68.13 (up from ₹28.88 in FY 2021). Revenue: ₹10.7b (up 57% from FY 2021). Net income: ₹813.9m (up 136% from FY 2021). Profit margin: 7.6% (up from 5.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 121% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 18
Full year 2022 earnings released: EPS: ₹68.13 (vs ₹28.88 in FY 2021) Full year 2022 results: EPS: ₹68.13 (up from ₹28.88 in FY 2021). Revenue: ₹10.7b (up 58% from FY 2021). Net income: ₹813.9m (up 136% from FY 2021). Profit margin: 7.6% (up from 5.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 123% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 14
Investor sentiment improved over the past week After last week's 18% share price gain to ₹1,490, the stock trades at a trailing P/E ratio of 27.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 948% over the past three years. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment improved over the past week After last week's 19% share price gain to ₹1,334, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 903% over the past three years. Reported Earnings • Feb 17
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹20.60 (up from ₹3.08 in 3Q 2021). Revenue: ₹2.98b (up 123% from 3Q 2021). Net income: ₹246.1m (up ₹209.2m from 3Q 2021). Profit margin: 8.3% (up from 2.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has increased by 114% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 12
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Chetan Shah was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Nov 12
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Chetan Shah was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 08
Second quarter 2022 earnings released: EPS ₹13.92 (vs ₹6.24 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹2.42b (up 33% from 2Q 2021). Net income: ₹166.3m (up 123% from 2Q 2021). Profit margin: 6.9% (up from 4.1% in 2Q 2021). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 18% share price gain to ₹696, the stock trades at a trailing P/E ratio of 21x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 207% over the past three years. Reported Earnings • Aug 18
First quarter 2022 earnings released: EPS ₹9.70 (vs ₹10.45 in 1Q 2021) The company reported a mediocre first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: ₹1.97b (up 31% from 1Q 2021). Net income: ₹115.9m (down 7.2% from 1Q 2021). Profit margin: 5.9% (down from 8.3% in 1Q 2021). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improved over the past week After last week's 16% share price gain to ₹674, the stock trades at a trailing P/E ratio of 23.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 170% over the past three years. Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improved over the past week After last week's 17% share price gain to ₹565, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 118% over the past three years. Reported Earnings • Jun 24
Full year 2021 earnings released: EPS ₹28.88 (vs ₹18.61 in FY 2020) The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2021 results: Revenue: ₹6.79b (flat on FY 2020). Net income: ₹344.9m (up 55% from FY 2020). Profit margin: 5.1% (up from 3.3% in FY 2020). Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 25% per year. Upcoming Dividend • Jun 24
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 01 July 2021. Payment date: 08 August 2021. Trailing yield: 0.2%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%). Reported Earnings • May 22
Full year 2021 earnings released: EPS ₹28.88 (vs ₹18.61 in FY 2020) The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2021 results: Revenue: ₹6.82b (flat on FY 2020). Net income: ₹344.9m (up 55% from FY 2020). Profit margin: 5.1% (up from 3.3% in FY 2020). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment improved over the past week After last week's 18% share price gain to ₹352, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 20% over the past three years. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improved over the past week After last week's 21% share price gain to ₹326, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 16% over the past three years. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improved over the past week After last week's 27% share price gain to ₹247, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 16x in the Chemicals industry in India. Total loss to shareholders of 6.7% over the past three years. 
